
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| TXG | +129.64% | -84.65% | -31.26% | -56% |
| S&P | +16.53% | +80.89% | +12.59% | +126% |
10x Genomics' Chromium platform empowers researchers to examine the full complexity of diverse cells.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $166.03M | 0.6% |
| Gross Profit | $115.01M | -4.4% |
| Gross Margin | 69.27% | -3.6% |
| Market Cap | $2.06B | 18.7% |
| Market Cap / Employee | $1.75M | 0.0% |
| Employees | 1.2K | -9.8% |
| Net Income | -$16,252.00K | 66.9% |
| EBITDA | -$2,772.00K | 92.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $473.97M | 37.8% |
| Accounts Receivable | $47.01M | -46.5% |
| Inventory | 56.3 | -32.2% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $73.38M | 0.1% |
| Short Term Debt | $10.99M | 18.3% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -4.44% | 14.9% |
| Return On Invested Capital | -29.51% | -3.2% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $39.00M | 512.1% |
| Operating Free Cash Flow | $40.78M | 704.3% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.50 | 2.02 | 1.88 | 2.63 | 9.32% |
| Price to Sales | 1.71 | 2.24 | 2.29 | 3.22 | 12.78% |
| Price to Tangible Book Value | 1.55 | 2.07 | 1.93 | 2.88 | 16.47% |
| Price to Free Cash Flow TTM | 23.59 | 25.35 | 17.97 | 15.93 | -84.78% |
| Enterprise Value to EBITDA | -18.74 | -1171.51 | -53.63 | -589.32 | 1501.92% |
| Free Cash Flow Yield | 4.2% | 3.9% | 5.6% | 6.3% | 557.14% |
| Return on Equity | -22.0% | -11.3% | -10.1% | -5.8% | -77.03% |
| Total Debt | $80.07M | $86.74M | $86.99M | $84.36M | 2.12% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.